Ministries considering a national electronic medical record are usually shown software. The more important decisions are not about software at all. They are about who owns the data, where it lives, who may use it and how the country avoids being locked in to a single supplier for decades.
Ownership: patients and the nation
Health data should be owned by patients and governed by national law. Contracts with technology suppliers should say so explicitly, and should forbid the sale or commercial exploitation of identifiable data. Research and public health uses should be permitted only with anonymization and national approval.
Hosting: in the country, under national control
An in-country data centre, operated with national partners and protected by encrypted backups and disaster recovery, keeps sensitive records within national jurisdiction. It also builds local technical capacity that outlasts any single project.
Standards: the antidote to lock-in
Open international standards such as HL7 FHIR let laboratories, pharmacies, insurers and hospitals exchange data, and let the nation change vendors without losing its records. Data portability should be a contractual obligation, tested before it is needed.
Design for real conditions
- Applications that work offline and synchronize when a connection returns
- Tolerance for power interruptions and low-bandwidth links
- Interfaces in the languages clinicians actually use
- Training, local champions and a national support desk
Use: public health intelligence
The return on a national record comes when anonymized data helps a ministry see disease outbreaks early, plan staff and medicines, and measure progress. That value belongs to the nation, and the governance should make sure it stays there.
Sovereignty is not a feature to add later. It is a design decision made on the first day.
